Skip to main content

Advertisement

Table 3 Comparison of metabolites concentrations and enzyme activities based on fatty acid ratios between the final and the baseline status (Final vs. Baseline) in group 1 (not meeting the NAFLD criteria at baseline and during the follow-up)

From: Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

Metabolites and enzyme activities Paired Student’s t-test (p-value) log2 (fold change)
1-Monoacylglycerophosphocholine 3.26E-02 −0.19
2-Monoacylglycerophosphocholine 3.59E-02 −0.20
Total Monoacylglycerophosphocholine 3.35E-02 −0.19
MonoetherglycerophosphocholineP_plasmenyles 3.60E-02 −0.20
MonoetherglycerophosphoethanolaminesO_plasmenyles 2.05E-03 −0.64
Total 1- Monoetherglycerophosphocholine 2.92E-02 −0.18
Total Lysophosphatidylcholines 1.57E-02 −0.21
Triacylglycerols 3.68E-02 −0.23
Sum of Triacylglycerols& Cholesteryl Esters 2.50E-02 −0.27
Stearoyl-CoA desaturase 1 (16:1n-7/16:0) 4.53E-02 0.09
  1. log2 (fold-change) and p-values follows the criterion of heatmap figure